SCHEMBL6672976

SCHEMBL6672976

CCCOP(=O)(Oc1cc(F)c2ncc(C(=O)NCc3ccc(Cl)cc3)c(O)c2c1)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.38
NR3C1 P04150 1/20 0.38
EGLN1 Q9GZT9 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
THRB P10828 1/20 0.35
CNR2 P34972 2/20 0.35
MAPT P10636 1/20 0.35
EPHX2 P34913 1/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PTGER4 P35408 1/20 0.34
PTGER2 P43116 1/20 0.34
GSK3B P49841 1/20 0.34
POLA1 P09884 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6199313 0.84 LMNA (0.39) LMNANR3C1EGLN1SMN1; SMN2THRB
SCHEMBL6672975 0.79 LMNA (0.38) LMNANR3C1EGLN1SMN1; SMN2THRB
SCHEMBL6198300 0.78 LMNA (0.40) LMNANR3C1EGLN1SMN1; SMN2THRB
SCHEMBL6666974 0.77 LMNA (0.39) LMNANR3C1EGLN1THRBCNR2
SCHEMBL6198141 0.76 EGLN1 (0.47) LMNANR3C1EGLN1CNR2MAPT
SCHEMBL8122619 0.76 NR3C1 (0.43) LMNANR3C1EGLN1SMN1; SMN2THRB
SCHEMBL6197986 0.76 EGLN1 (0.49) LMNANR3C1EGLN1SMN1; SMN2CNR2
SCHEMBL6197926 0.75 LMNA (0.45) LMNANR3C1EGLN1SMN1; SMN2THRB
SCHEMBL6671910 0.75 P2RX3 (0.36) LMNANR3C1EGLN1THRBCNR2
SCHEMBL6200535 0.74 EGLN1 (0.42) LMNANR3C1EGLN1SMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO claimed
WO-2004019932-A1 METHOD OF PREVENTING OR TREATING ATHEROSCLEROSIS OR RESTENOSIS PHARMACIA & UPJOHN COMPANY (US) 2004-03-11 WO disclosed